Masimo | MASI - 負債



負債 変化する 日付
Abbott USD 13.86B 919M 2025-12
Accuray USD 170.24M 4.52M 2024-09
Align Technology USD 114.45M 6.82M 2025-12
AngioDynamics USD 6.3M 6.3M 2025-02
Artivion USD 317.78M 619K 2024-12
AtriCure USD 73.38M 3.35M 2025-12
Avanos Medical USD 129.1M 4.6M 2025-12
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
General Electric Aerospace USD 20.28B 217M 2026-03
Globus Medical USD 118.66M 687K 2025-12
Haemonetics USD 1.22B 5K 2025-12
Inogen USD 0 0 2022-06
Insulet USD 949.2M 65.6M 2025-12
Integra LifeSciences USD 2.04B 6.27M 2026-03
Intuitive Surgical USD 0 0 2025-03
Medtronic USD 28.07B 1.03B 2025-12
Orthofix International USD 137.23M 338K 2024-09
Owens Minor USD 1.95B 91.18M 2025-03
ResMed USD 847.72M 1.37M 2025-12
Steris USD 2.05B 4.8M 2025-12
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Teleflex USD 2.73B 43.5M 2025-12
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03